Barclays PLC Wave Life Sciences Ltd. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Barclays PLC holds 159,241 shares of WVE stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

159,241

Previous 159,241 -0.0%

Holding current value

$2.15 Million

Previous $1.31 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$5.12 - $9.01 $514,549 - $905,486	100,498 Added 171.08%	159,241 $1.31 Million
Q2 2024 Aug 14, 2024	SELL	$4.38 - $6.48 $153,523 - $227,130	-35,051 Reduced 37.37%	58,743 $294,000
Q1 2024 May 15, 2024	SELL	$3.54 - $6.84 $309,654 - $598,315	-87,473 Reduced 48.26%	93,794 $579,000
Q4 2023 Feb 15, 2024	BUY	$4.16 - $6.87 $681,158 - $1.12 Million	163,740 Added 934.22%	181,267 $917,000
Q3 2023 Nov 07, 2023	SELL	$3.56 - $5.75 $4,663 - $7,532	-1,310 Reduced 6.95%	17,527 $100,000
Q2 2023 Aug 03, 2023	SELL	$3.51 - $4.69 $43,822 - $58,554	-12,485 Reduced 39.86%	18,837 $69,000
Q1 2023 May 04, 2023	SELL	$3.58 - $6.3 $39,279 - $69,123	-10,972 Reduced 25.94%	31,322 $136,000
Q4 2022 Feb 13, 2023	BUY	$3.18 - $7.0 $122,630 - $269,941	38,563 Added 1033.58%	42,294 $296,000
Q3 2022 Nov 03, 2022	BUY	$2.37 - $4.28 $8,842 - $15,968	3,731 New	3,731 $13,000
Q2 2022 Aug 12, 2022	SELL	$1.23 - $3.25 $9,078 - $23,988	-7,381 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.0 - $3.28 $92,700 - $152,028	-46,350 Reduced 86.26%	7,381 $14,000
Q4 2021 Feb 14, 2022	BUY	$3.14 - $5.15 $119,677 - $196,287	38,114 Added 244.05%	53,731 $169,000
Q3 2021 Nov 09, 2021	BUY	$4.89 - $7.12 $52,914 - $77,045	10,821 Added 225.63%	15,617 $77,000
Q2 2021 Aug 13, 2021	SELL	$5.65 - $7.47 $127,757 - $168,911	-22,612 Reduced 82.5%	4,796 $32,000
Q1 2021 May 13, 2021	SELL	$5.61 - $12.01 $1.11 Million - $2.37 Million	-197,072 Reduced 87.79%	27,408 $154,000
Q4 2020 Feb 11, 2021	BUY	$6.99 - $9.26 $820,737 - $1.09 Million	117,416 Added 109.67%	224,480 $1.77 Million
Q3 2020 Nov 12, 2020	BUY	$8.49 - $19.54 $587,338 - $1.35 Million	69,180 Added 182.61%	107,064 $909,000
Q2 2020 Aug 12, 2020	BUY	$7.44 - $11.29 $37,877 - $57,477	5,091 Added 15.52%	37,884 $394,000
Q1 2020 May 13, 2020	BUY	$6.94 - $14.22 $70,996 - $145,470	10,230 Added 45.34%	32,793 $308,000
Q4 2019 Feb 10, 2020	SELL	$7.99 - $37.6 $7,159 - $33,689	-896 Reduced 3.82%	22,563 $180,000
Q3 2019 Nov 14, 2019	BUY	$19.17 - $27.4 $127,422 - $182,127	6,647 Added 39.54%	23,459 $482,000
Q2 2019 Aug 14, 2019	BUY	$22.93 - $42.84 $250,922 - $468,798	10,943 Added 186.45%	16,812 $439,000
Q1 2019 May 15, 2019	BUY	$32.69 - $47.91 $191,857 - $281,183	5,869 New	5,869 $228,000
Q4 2018 Feb 14, 2019	SELL	$37.1 - $50.11 $396,487 - $535,525	-10,687 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$36.35 - $55.2 $76,444 - $116,085	-2,103 Reduced 16.44%	10,687 $534,000
Q2 2018 Aug 14, 2018	SELL	$33.85 - $50.65 $115,462 - $172,767	-3,411 Reduced 21.05%	12,790 $490,000
Q1 2018 May 15, 2018	BUY	$32.45 - $54.7 $52,796 - $88,996	1,627 Added 11.16%	16,201 $650,000
Q4 2017 Feb 14, 2018	BUY	$21.8 - $39.35 $119,878 - $216,385	5,499 Added 60.6%	14,574 $512,000
Q3 2017 Nov 14, 2017	BUY	$16.4 - $25.05 $148,830 - $227,328	9,075	9,075 $198,000

Others Institutions Holding WVE

# of Institutions

164

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.17B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account